Unknown

Dataset Information

0

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model.


ABSTRACT: Increasing evidence from epidemiological and pathological studies suggests a role of the immune system in the initiation and progression of multiple cancers, including prostate cancer. Reports on the contribution of the adaptive immune system are contradictive, since both suppression and acceleration of disease development have been reported. This study addresses the functional role of lymphocytes in prostate cancer development using a genetically engineered mouse model (GEMM) of human c-Myc driven prostate cancer (Hi-Myc mice) combined with B and T cell deficiency (RAG1-/- mice). From a pre-cancerous stage on, Hi-Myc mice showed higher accumulation of immune cells in their prostates then wild-type mice, of which macrophages were the most abundant. The onset of invasive adenocarcinoma was delayed in Hi-MycRAG1-/- compared to Hi-Myc mice and associated with decreased infiltration of leukocytes into the prostate. In addition, lower levels of the cytokines CXCL2, CCL5 and TGF-?1 were detected in Hi-MycRAG1-/- compared to Hi-Myc mouse prostates. These results from a GEMM of prostate cancer provide new insights into the promoting role of the adaptive immune system in prostate cancer development. Our findings indicate that the endogenous adaptive immune system does not protect against de novo prostate carcinogenesis in Hi-Myc transgenic mice, but rather accelerates the formation of invasive adenocarcinomas. This may have implications for the development of novel treatment strategies.

SUBMITTER: Melis MHM 

PROVIDER: S-EPMC5706841 | biostudies-other | 2017 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model.

Melis Monique H M MHM   Nevedomskaya Ekaterina E   van Burgsteden Johan J   Cioni Bianca B   van Zeeburg Hester J T HJT   Song Ji-Ying JY   Zevenhoven John J   Hawinkels Lukas J A C LJAC   de Visser Karin E KE   Bergman Andries M AM  

Oncotarget 20170928 55


Increasing evidence from epidemiological and pathological studies suggests a role of the immune system in the initiation and progression of multiple cancers, including prostate cancer. Reports on the contribution of the adaptive immune system are contradictive, since both suppression and acceleration of disease development have been reported. This study addresses the functional role of lymphocytes in prostate cancer development using a genetically engineered mouse model (GEMM) of human c-Myc dri  ...[more]

Similar Datasets

| S-EPMC6460650 | biostudies-literature
| S-EPMC2822708 | biostudies-literature
| S-EPMC5581066 | biostudies-literature
| S-EPMC3769880 | biostudies-other
| S-EPMC3735836 | biostudies-literature
| S-EPMC4648373 | biostudies-literature
| S-EPMC5266385 | biostudies-literature
| S-EPMC6677832 | biostudies-literature
| S-EPMC5833437 | biostudies-literature
| S-EPMC2902987 | biostudies-literature